International Flavors & Fragrances (IFF) Earnings Date & Reports

For Q1 2026, IFF posted net sales of $2.741 billion, a 4% decline from $2.843 billion in Q1 2025, primarily due to divestiture impacts. However, this topped analyst consensus of $2.64–$2.65 billion. On a comparable currency-neutral basis, sales grew 3%, fueled by volume increases across all segments.

Reported net income attributable to shareholders was $169 million, or $0.66 per diluted share, swinging from a $1.018 billion loss (or $(3.98) per share) in Q1 2025 due to a prior goodwill impairment. Adjusted EPS excluding amortization hit $1.25, exceeding expectations of $1.07–$1.10 and improving on the prior year.

Adjusted operating EBITDA stood at $568 million (20.7% margin), slightly below prior-year $578 million reported but up 8% currency-neutral, thanks to productivity and lower costs. Segment highlights included Taste (+2% currency-neutral sales, +18% EBITDA), Health & Biosciences (+5% sales, +7% EBITDA), Scent (+1% sales), and Food Ingredients (+3% sales, +12% EBITDA).

Guidance for full-year 2026 was reaffirmed: sales $10.5–$10.8 billion, adjusted operating EBITDA $2.05–$2.15 billion, with 1–4% currency-neutral sales growth and 3–8% EBITDA growth, accounting for divestiture headwinds.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization (market cap), technical indicators, price patterns, and performance metrics. The screener identifies trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore it today to enhance your research process.

Market Reaction and Investor Sentiment

Following the May 5 after-market release, IFF shares surged nearly 6% to $74.98 in after-hours trading from a $70.77 close, reflecting approval of the earnings beat and reaffirmed guidance. Sentiment turned positive as investors focused on volume growth, cash flow strength ($257 million operating cash flow), and portfolio streamlining, offsetting reported sales decline. Analysts noted the results derisk the year amid economic uncertainty.

Forward Outlook and Key Factors to Monitor

IFF's reaffirmed 2026 guidance signals confidence despite divestiture impacts (~5% adverse on sales and EBITDA) and an unsettled macro environment. Comparable currency-neutral sales growth of 1–4% and EBITDA growth of 3–8% hinge on continued volume momentum across core segments like Taste and Health & Biosciences.

Key to watch: Progress on the Food Ingredients sale process, which could unlock value and sharpen focus on higher-margin businesses. Operational cash flow trends remain strong, supporting debt reduction (net debt to adjusted EBITDA at 2.5x) and dividends.

Inflation pass-through, productivity gains, and innovation pipelines will be critical amid cost pressures. The earnings call on May 6 provides further color on demand in food, fragrance, and biosciences, plus FX impacts (neutral on EBITDA). Upcoming catalysts include Q2 results and potential divestiture announcements, balancing industry dynamics like consumer spending shifts.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations